scholarly journals TRENDS AND INPATIENT OUTCOMES OF HEART FAILURE PATIENTS WITH CONCURRENT DIAGNOSIS OF ACUTE EXACERBATION OF COPD: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE 2004-2014

2021 ◽  
Vol 77 (18) ◽  
pp. 1106
Author(s):  
Asim Kichloo ◽  
Abdul Mannan Khan Minhas ◽  
Shakeel Jamal ◽  
Michael Albosta ◽  
Jagmeet Singh ◽  
...  
Diagnostics ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 554
Author(s):  
Silvia Terraneo ◽  
Rocco Francesco Rinaldo ◽  
Giuseppe Francesco Sferrazza Papa ◽  
Fulvia Ribolla ◽  
Carlo Gulotta ◽  
...  

Discriminating between cardiac and pulmonary dyspnea is essential for patients’ management. We investigated the feasibility and ability of forced oscillation techniques (FOT) in distinguishing between acute exacerbation of COPD (AECOPD), and acute decompensated heart failure (ADHF) in a clinical emergency setting. We enrolled 49 patients admitted to the emergency department (ED) for dyspnea and acute respiratory failure for AECOPD, or ADHF, and 11 healthy subjects. All patients were able to perform bedside FOT measurement. Patients with AECOPD showed a significantly higher inspiratory resistance at 5 Hz, Xrs5 (179% of predicted, interquartile range, IQR 94–224 vs. 100 IQR 67–149; p = 0.019), and a higher inspiratory reactance at 5 Hz (151%, IQR 74–231 vs. 57 IQR 49–99; p = 0.005) than patients with ADHF. Moreover, AECOPD showed higher heterogeneity of ventilation (respiratory system resistance difference at 5 and 19 Hz, Rrs5-19: 1.49 cmH2O/(L/s), IQR 1.03–2.16 vs. 0.44 IQR 0.22–0.76; p = 0.030), and a higher percentage of flow limited breaths compared to ADHF (10%, IQR 0–100 vs. 0 IQR 0–12; p = 0.030). FOT, which resulted in a suitable tool to be used in the ED setting, has the ability to identify distinct mechanical properties of the respiratory system in AECOPD and ADHF.


2021 ◽  
pp. 22-24
Author(s):  
Ikbal Ali ◽  
Ajith Kumar M S ◽  
Mahendra Kumar Meena ◽  
Agnihotri SP

BACKGROUND: Cardiovascular disease is one of the major causes of mortality and is frequently unrecognized in COPD patients. Serum N-terminal pro-brain natriuretic peptide (NT-pro BNP) is an established risk factor in patients with Heart failure. However NT-pro BNP levels may also be elevated during acute exacerbation of COPD(AECOPD) even without heart failure. Objectives of the study are-(a)To nd the levels of Serum NT-pro BNP in AECOPD patients. (b) To nd out the association of Serum NT-pro BNP with clinical and physiological parameters in AECOPD patients. METHODS: This cross-sectional study was carried out on 60 AECOPD patients admitted in department of Respiratory Medicine, Institute of Respiratory Diseases, SMS Medical College, Jaipur during July 2019–June 2020. Clinical data including vitals, Electrocardiogram (ECG), arterial blood gas analysis (ABG), Serum NT-pro BNP levels were assessed. Previous ECG and spirometry details were also recorded. RESULTS: The mean levels of Serum NT-pro BNP were higher in very severe COPD patients. The association of Serum NT-pro BNP were signicantly higher with AECOPD patients having increased exacerbations per year, longer hospital stay duration, decreasing Spo2 levels and decreasing blood pH levels. CONCLUSION: Patients with AECOPD who had elevated Serum NT-pro BNP levels had higher likelihood of ICU admission and longer hospital stay. Thus elevated NT-pro BNP levels warrants the need of Intensive care for early and better management of COPD patients.


2016 ◽  
Vol 3 (1) ◽  
pp. 56-64
Author(s):  
M.G.Krishna Murthy ◽  
◽  
Tarigopula Pramod Kumar ◽  
M. Kiran kumar

Author(s):  
Elio Monsour ◽  
Lyd-Marie Rodriguez ◽  
Randa Abdelmasih ◽  
Kubra Tuna ◽  
Khalid Abusaada

Sign in / Sign up

Export Citation Format

Share Document